Prothena | PRTA - Marktkapitalisierung

Aktienkurs
10.75
Täglich Wechseln
0.02 0.19%
Monatlich
15.47%
Jährlich
10.82%
Q2 Prognose
10.43




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Exelixis USD 11.75B 959M 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
MacroGenics USD 102M 4M 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Prothena USD 514M 11M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12